Teva Pharmaceuticals, a subsidiary of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), has struck an agreement with Georgia’s Attorney General (AG) to resolve the state’s price-fixing charges against Teva. Teva will pay the state $3.346 million as part of the settlement, and once paid, the state will dismiss all of its claims against Teva and its affiliates.
Share Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) price swings at $8.24 with percentage change of 2.11% in most recent trading session on Monday. The firm has price volatility of 3.58% for a week and 3.06% for a month. Narrow down focus to firm performance, its weekly performance was +2.15% and monthly performance was -10.73%. The stock price of TEVA is drop from its 20 days moving average with -3.79% and decrease from 50 days moving average with -11.83%.
Teva is dedicated to conducting business in accordance with all applicable laws. Teva has also committed, as part of its settlement with Georgia, to maintain its strong antitrust training and compliance activities throughout the United States.
Teva Pharmaceuticals Releases Huntington Disease Website
Teva Pharmaceuticals recently launched the Honestly HD website, which aims to provide information, inspiration, and resources to help people understand what to expect with Huntington’s Disease (HD) chorea, one of the most visible and treatable symptoms of HD, and how to discuss preserving independence with their doctor. A Twitter channel, @HonestlyHD, has been developed in addition to the newly launched site to further assist the HD community and enhance the resources currently accessible through the Honestly HD Facebook community, which provides a virtual place for sharing personal experiences and information.
“There is so much to learn about HD that it is easy to become overwhelmed and confused. While there is no treatment for HD, many symptoms may be treated, which can help to alleviate some of the difficulties associated with the illness. Early chorea therapy, for example, can help you stay independent for a longer period of time “Dr. Victor W. Sung, Chair of HDSA’s National Board of Trustees and Director of the HDSA Center of Excellence in Alabama, stated No. 2. “Truly, HD gives a single location for patients and families impacted by HD to acquire beneficial information and services, as well as hear about the experiences of others to feel a feeling of community.”